Advancing Precision Oncology: Digital Twins and Symbolic AI in Triple-Negative Breast Cancer

In a collaborative effort between University College Institute (UCL) and the University of Cambridge, researchers have engineered personalized computational frameworks—often termed tumor "digital twins"—to forecast therapeutic responses and overcome drug…

Continue Reading Advancing Precision Oncology: Digital Twins and Symbolic AI in Triple-Negative Breast Cancer

CHMP Backs Datroway for First-Line Treatment of Metastatic Triple-Negative Breast Cancer in EU

As reported on Stock Titan, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Datroway® (datopotamab deruxtecan) as a…

Continue Reading CHMP Backs Datroway for First-Line Treatment of Metastatic Triple-Negative Breast Cancer in EU

Revolutionary Approach to Triple-Negative Breast Cancer: Telomir-1 Advances Toward Clinical Trials

Telomir Pharmaceuticals has taken a significant step forward in the development of a novel therapeutic agent for one of oncology's most challenging cancers. As reported by Pharmaceutical Technology, the company…

Continue Reading Revolutionary Approach to Triple-Negative Breast Cancer: Telomir-1 Advances Toward Clinical Trials